核心概念
The author discusses the transformative impact of Ozempic and similar drugs on weight loss, highlighting their potential to revolutionize obesity treatment and reshape societal norms around body image.
要約
A century ago, August Krogh's interest in diabetes led to the creation of insulin. Novo Nordisk developed GLP-1 analogues that evolved into successful diabetes treatments. The emergence of once-weekly formulations like Ozempic has shown remarkable weight-loss results, sparking hope and excitement among patients and healthcare providers. These medications have the potential to address the obesity epidemic by offering effective solutions for weight management.
統計
In clinical trials, people who've taken Ozempic have lost an average of fifteen percent of their weight.
Phase II trials of retatrutide showed that people taking the highest dosage lost nearly a quarter of their body weight.
Roughly two-thirds of real-world patients discontinue Ozempic within a year due to side effects.
引用
"People have used the drugs to get into wedding shape, and have taken out credit cards or second jobs to pay for them."
"It’s an unprecedented situation," Christian Hendershot, a University of North Carolina clinical psychologist who is studying semaglutide’s effect on alcohol use, told me.